Linda M Delahanty1,2, Douglas E Levy3,4, Yuchiao Chang3,5, Bianca C Porneala5, Valerie Goldman6, Jeanna McCarthy6, Laurie Bissett6, Anthony Romeo Rodriguez6, Barbara Chase5,7, Rajani LaRocca3,5,8, Amy Wheeler3,5,9, Deborah J Wexler6,3. 1. Diabetes Unit, Department of Medicine, Massachusetts General Hospital (MGH) Diabetes Research Center, Boston, MA, USA. delahanty.linda@mgh.harvard.edu. 2. Harvard Medical School, Boston, MA, USA. delahanty.linda@mgh.harvard.edu. 3. Harvard Medical School, Boston, MA, USA. 4. Mongan Institute Health Policy Research Center, MGH, Boston, MA, USA. 5. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. 6. Diabetes Unit, Department of Medicine, Massachusetts General Hospital (MGH) Diabetes Research Center, Boston, MA, USA. 7. MGH Chelsea Health Center, Boston, MA, USA. 8. MGH Charlestown Health Center, Boston, MA, USA. 9. MGH Revere Health Center, Boston, MA, USA.
Abstract
BACKGROUND: Intensive lifestyle interventions (LI) improve outcomes in obesity and type 2 diabetes but are not currently available in usual care. OBJECTIVE: To compare the effectiveness and costs of two group LI programs, in-person LI and telephone conference call (telephone LI), to medical nutrition therapy (MNT) on weight loss in primary care patients with type 2 diabetes. DESIGN: A randomized, assessor-blinded, practice-based clinical trial in three community health centers and one hospital-based practice affiliated with a single health system. PARTICIPANTS: A total of 208 primary care patients with type 2 diabetes, HbA1c 6.5 to < 11.5, and BMI > 25 kg/m2 (> 23 kg/m2 in Asians). INTERVENTIONS: Dietitian-delivered in-person or telephone group LI programs with medication management or MNT referral. MAIN MEASURES: Primary outcome: mean percent weight change. SECONDARY OUTCOMES: 5% and 10% weight loss, change in HbA1c, and cost per kilogram lost. KEY RESULTS: Participants' mean age was 62 (SD 10) years, 45% were male, and 77% were White, with BMI 35 (SD 5) kg/m2 and HbA1c 7.7 (SD 1.2). Seventy were assigned to in-person LI, 72 to telephone LI, and 69 to MNT. The mean percent weight loss (95% CI) at 6 and 12 months was 5.6% (4.4-6.8%) and 4.6% (3.1-6.1%) for in-person LI, 4.6% (3.3-6.0%) and 4.8% (3.3-6.2%) for telephone LI, and 1.1% (0.2-2.0%) and 2.0% (0.9-3.0%) for MNT, with statistically significant differences between each LI arm and MNT (P < 0.001) but not between LI arms (P = 0.63). HbA1c improved in all participants. Compared with MNT, the incremental cost per kilogram lost was $789 for in-person LI and $1223 for telephone LI. CONCLUSIONS: In-person LI or telephone group LI can achieve good weight loss outcomes in primary care type 2 diabetes patients at a reasonable cost. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02320253.
BACKGROUND: Intensive lifestyle interventions (LI) improve outcomes in obesity and type 2 diabetes but are not currently available in usual care. OBJECTIVE: To compare the effectiveness and costs of two group LI programs, in-person LI and telephone conference call (telephone LI), to medical nutrition therapy (MNT) on weight loss in primary care patients with type 2 diabetes. DESIGN: A randomized, assessor-blinded, practice-based clinical trial in three community health centers and one hospital-based practice affiliated with a single health system. PARTICIPANTS: A total of 208 primary care patients with type 2 diabetes, HbA1c 6.5 to < 11.5, and BMI > 25 kg/m2 (> 23 kg/m2 in Asians). INTERVENTIONS: Dietitian-delivered in-person or telephone group LI programs with medication management or MNT referral. MAIN MEASURES: Primary outcome: mean percent weight change. SECONDARY OUTCOMES: 5% and 10% weight loss, change in HbA1c, and cost per kilogram lost. KEY RESULTS: Participants' mean age was 62 (SD 10) years, 45% were male, and 77% were White, with BMI 35 (SD 5) kg/m2 and HbA1c 7.7 (SD 1.2). Seventy were assigned to in-person LI, 72 to telephone LI, and 69 to MNT. The mean percent weight loss (95% CI) at 6 and 12 months was 5.6% (4.4-6.8%) and 4.6% (3.1-6.1%) for in-person LI, 4.6% (3.3-6.0%) and 4.8% (3.3-6.2%) for telephone LI, and 1.1% (0.2-2.0%) and 2.0% (0.9-3.0%) for MNT, with statistically significant differences between each LI arm and MNT (P < 0.001) but not between LI arms (P = 0.63). HbA1c improved in all participants. Compared with MNT, the incremental cost per kilogram lost was $789 for in-person LI and $1223 for telephone LI. CONCLUSIONS: In-person LI or telephone group LI can achieve good weight loss outcomes in primary care type 2 diabetes patients at a reasonable cost. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02320253.
Entities:
Keywords:
cost-effectiveness; lifestyle intervention; primary care; type 2 diabetes; weight loss interventions
Authors: Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski Journal: N Engl J Med Date: 2013-06-24 Impact factor: 91.245
Authors: Thomas A Wadden; Delia Smith West; Linda Delahanty; John Jakicic; Jack Rejeski; Don Williamson; Robert I Berkowitz; David E Kelley; Christine Tomchee; James O Hill; Shiriki Kumanyika Journal: Obesity (Silver Spring) Date: 2006-05 Impact factor: 5.002
Authors: Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; David C Grossman; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong Journal: JAMA Date: 2018-09-18 Impact factor: 56.272
Authors: Michael S Lawlor; Caroline S Blackwell; Scott P Isom; Jeffrey A Katula; Mara Z Vitolins; Timothy M Morgan; David C Goff Journal: Am J Prev Med Date: 2013-04 Impact factor: 5.043
Authors: Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski Journal: Diabetes Care Date: 2007-03-15 Impact factor: 19.112
Authors: Alison B Evert; Michelle Dennison; Christopher D Gardner; W Timothy Garvey; Ka Hei Karen Lau; Janice MacLeod; Joanna Mitri; Raquel F Pereira; Kelly Rawlings; Shamera Robinson; Laura Saslow; Sacha Uelmen; Patricia B Urbanski; William S Yancy Journal: Diabetes Care Date: 2019-04-18 Impact factor: 19.112
Authors: Alison B Evert; Jackie L Boucher; Marjorie Cypress; Stephanie A Dunbar; Marion J Franz; Elizabeth J Mayer-Davis; Joshua J Neumiller; Robin Nwankwo; Cassandra L Verdi; Patti Urbanski; William S Yancy Journal: Diabetes Care Date: 2013-10-09 Impact factor: 19.112
Authors: Linda M Delahanty; Thomas A Wadden; Pamela J Goodwin; Catherine M Alfano; Cynthia A Thomson; Melinda L Irwin; Marian L Neuhouser; Tracy E Crane; Elizabeth Frank; Patricia A Spears; Bonnie P Gillis; Dawn L Hershman; Electra D Paskett; Judith Hopkins; Vanessa Bernstein; Vered Stearns; Julia White; Clifford Hudis; Eric P Winer; Lisa A Carey; Ann H Partridge; Jennifer A Ligibel Journal: Obesity (Silver Spring) Date: 2022-01 Impact factor: 9.298
Authors: Ping Zhang; Karen M Atkinson; George A Bray; Haiying Chen; Jeanne M Clark; Mace Coday; Gareth R Dutton; Caitlin Egan; Mark A Espeland; Mary Evans; John P Foreyt; Frank L Greenway; Edward W Gregg; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; Peter J Huckfeldt; Sharon D Jackson; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Tina Killean; William C Knowler; Mary Korytkowski; Cora E Lewis; Nisa M Maruthur; Sara Michaels; Maria G Montez; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; Bruce Redmon; Julia T Rushing; Helmut Steinburg; Thomas A Wadden; Rena R Wing; Holly Wyatt; Susan Z Yanovski Journal: Diabetes Care Date: 2020-11-09 Impact factor: 19.112
Authors: Seth A Berkowitz; Yuchiao Chang; Bianca Porneala; Sara J Cromer; Deborah J Wexler; Linda M Delahanty Journal: BMJ Open Diabetes Res Care Date: 2020-09